Success Metrics

Completion Rate
0%(0/4)
Active Trials
0(0%)
Terminated
4(100%)

Phase Distribution

Ph phase_3
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
4(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 4 finished

Non-Completion Rate

100.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(4)

Detailed Status

Terminated4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 34 (100.0%)

Trials by Status

terminated4100%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_3

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01901328
terminatedphase_3

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01696643
terminatedphase_3

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01901302
terminatedphase_3

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01901341

Clinical Trials (4)

Showing 4 of 4 trials
NCT01901328Phase 3

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Terminated
NCT01696643Phase 3

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Terminated
NCT01901302Phase 3

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Terminated
NCT01901341Phase 3

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4